Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04806165 · ClinicalTrials.gov registry record · NA

Treatment Uptake Chatbot for Eating Disorders

A NA study of Eating Disorders, sponsored by Washington University School of Medicine.

Completed
Registry status
NA
Development phase
205
Enrollment target
1
Study location

NCT04806165 is a NA study of Eating Disorders that has completed, run by Washington University School of Medicine. The registered enrollment target is 205 participants, below the 317-participant average among 37 other Eating Disorders trials with a reported enrollment target (35% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04806165, a NA study of Eating Disorders, has completed, sponsored by Washington University School of Medicine.

COMPLETED
Registry status
NA
Development phase
205 participants
Enrollment target
1
Study location

Study Summary

Eating disorders (EDs) are serious mental illnesses associated with high morbidity and mortality, clinical impairment, and comorbid psychopathology. Although evidence-based treatments for EDs have been established, the treatment gap is wide. Indeed, \<20% of individuals with EDs receive treatment. There is need for a novel solution not only to identify individuals with EDs but also to encourage mental health services use and to address treatment barriers. This study aims to implement a conversational agent or "chatbot" that is optimized to increase mental health services use among individuals with EDs through such features as: 1) education on the seriousness and consequences of EDs; 2) engaging the user in motivational interviewing to overcome barriers to care; 3) providing a personalized recommendation for seeking intervention; 4) repeated check-ins with the user to encourage follow-up with care. This study will utilize a randomized optimization trial with adults who have completed screening on the National Eating Disorders Association (NEDA) website and screen positive for an ED but are not in treatment to determine chatbot feasibility and to generate data on the effect of the chatbot on motivation for treatment and mental health services use. This trial will employ the Multiphase Optimization Strategy framework, using a 2\^4 full factorial design, to randomly assign participants to a combination of the four proposed intervention components (n=16 conditions) to isolate the active ingredients.

Conditions Studied

Interventions

  • BEHAVIORAL Motivational Interviewing
  • BEHAVIORAL Repeated Administration
  • BEHAVIORAL Personalized Recommendation
  • BEHAVIORAL Core Modules Only
  • BEHAVIORAL Motivational Interviewing, Personalized Recommendation, Repeated Administration

Study Locations (1)

Missouri

  • Washington University School of Medicine - St Louis

Trial Details

FieldValue
Enrollment Target 205 participants
Start Date 2021-03-09
Est. Completion 2022-05-09
Phase NA

What the Registry Record Tells You About NCT04806165

The ClinicalTrials.gov registry entry for NCT04806165 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 205 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 317-participant average among 37 other Eating Disorders trials with a reported enrollment target (35% lower). The listed sponsor is Washington University School of Medicine, which has 1,502 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Eating Disorders appearing as the primary indexed condition, and to 5 interventions - of which Motivational Interviewing is the first listed.

NCT04806165 reports 1 study location spanning 1 distinct geographic area - top geographies include Missouri.

Frequently Asked Questions

What is clinical trial NCT04806165 about?

NCT04806165 is a clinical study titled "Treatment Uptake Chatbot for Eating Disorders". Eating disorders (EDs) are serious mental illnesses associated with high morbidity and mortality, clinical impairment, and comorbid psychopathology. Although evidence-based treatments for EDs have been established, the treatment gap is wide. Indeed, \<20% of individuals with EDs receive treatment. T...

What is the current status of trial NCT04806165?

This trial is currently completed. It is a NA study. The enrollment target is 205 participants. The study started on 2021-03-09. Estimated completion is 2022-05-09.

What conditions does trial NCT04806165 study?

This clinical trial studies the following conditions: Eating Disorders.

What interventions are being tested in trial NCT04806165?

The interventions under investigation include: Motivational Interviewing (BEHAVIORAL), Repeated Administration (BEHAVIORAL), Personalized Recommendation (BEHAVIORAL), Core Modules Only (BEHAVIORAL), Motivational Interviewing, Personalized Recommendation, Repeated Administration (BEHAVIORAL).

Who is sponsoring clinical trial NCT04806165?

This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04806165 being conducted?

This trial has 1 study location across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Eating Disorders

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.